News
Molina Healthcare Q2 Earnings Call Highlights
Key Points
- Interested in Molina Healthcare, Inc? Here are five stocks we like better.
- Molina Healthcare beat second-quarter expectations with adjusted EPS of $1.51 on $10.2 billion of premium
Quest Diagnostics Q2 Earnings Call Highlights
Key Points
- Interested in Quest Diagnostics Incorporated? Here are five stocks we like better.
- Quest Diagnostics posted strong Q2 results, with revenue up 10.2% to $3.04 billion and adjusted
Community Health Systems Q2 Earnings Call Highlights
Key Points
- Interested in Community Health Systems, Inc.? Here are five stocks we like better.
- Community Health Systems cut its full-year 2026 outlook after second-quarter results came in below
FirstService Q2 Earnings Call Highlights
Key Points
- Interested in FirstService Corporation? Here are five stocks we like better.
- FirstService posted modest Q2 growth, with revenue up 2% year over year to $1.45 billion, adjusted
Organon & Co. Shareholders Clear Sun Pharma Merger Deal
Key Points
- Interested in Organon & Co.? Here are five stocks we like better.
- Organon shareholders approved the company’s proposed merger with Sun Pharmaceutical Holdings USA, clearing a major
AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle
Key Points
- Interested in Advanced Micro Devices, Inc.? Here are five stocks we like better.
- AMD and Anthropic announced a strategic partnership tied to up to 2 gigawatts of AMD Instinct MI450
T-Mobile US Q2 Earnings Call Highlights
Key Points
- Interested in T-Mobile US, Inc.? Here are five stocks we like better.
- Strong Q2 operating performance: T-Mobile said it had an “extraordinary” quarter, adding 277,000 postpaid net
Sartorius Aktiengesellschaft Q2 Earnings Call Highlights
Key Points
- Interested in Sartorius Aktiengesellschaft? Here are five stocks we like better.
- Sartorius reported solid first-half growth, with constant-currency sales up 7.7% and underlying
EQS-News: Gerresheimer nimmt neues Werk in Zhenjiang Dagang, China, in Betrieb
EQS-News: Gerresheimer nimmt neues Werk in Zhenjiang Dagang, China, in Betrieb
EQS-News: Fresenius gründet Venture-Fonds mit mindestens 200 Millionen Euro und treibt Innovationen im Gesundheitswesen voran
EQS-News: Fresenius gründet Venture-Fonds mit mindestens 200 Millionen Euro und treibt Innovationen im Gesundheitswesen voran
EQS-News: Sartorius setzt positive Dynamik fort und wächst weiter profitabel
EQS-News: Sartorius setzt positive Dynamik fort und wächst weiter profitabel
[Ad-hoc-Mitteilung gemäss Art. 53 KR] Roche setzt starke Dynamik in erstem Halbjahr 2026 mit Umsatzwachstum von +6% zu konstanten Wechselkursen fort; -2% in CHF aufgrund deutlicher Aufwertung des Schweizer Frankens
- Konzernverkäufe stiegen in den ersten sechs Monaten um 6% zu konstanten Wechselkursen (CER1; in CHF ausgewiesen -2% und auf USD-Basis2 8%) aufgrund hoher Nachfrage nach innovativen Medikamenten
[Ad-hoc-Mitteilung gemäss Art. 53 KR] Roche setzt starke Dynamik in erstem Halbjahr 2026 mit Umsatzwachstum von +6% zu konstanten Wechselkursen fort; -2% in CHF aufgrund deutlicher Aufwertung des Schweizer Frankens
- Konzernverkäufe stiegen in den ersten sechs Monaten um 6% zu konstanten Wechselkursen (CER1; in CHF ausgewiesen -2% und auf USD-Basis2 8%) aufgrund hoher Nachfrage nach innovativen Medikamenten
Bayer Aktie: Ruveon zieht 446-Prozent-Zollantrag zurück
Bayer vollzieht in dieser Woche einen bemerkenswerten Rückzieher. Der Konzern zieht einen umstrittenen Zollantrag…
Der Beitrag Bayer Aktie: Ruveon zieht 446-Prozent-Zollantrag zurück erschien zuerst
Ocular Therapeutix Eyes Q4 AXPAXLI NDA After FDA Alignment
Key Points
- Interested in Ocular Therapeutix, Inc.? Here are five stocks we like better.
- Ocular Therapeutix says it remains on track to file an NDA for AXPAXLI in wet age-related macular
Knight-Swift Transportation Q2 Earnings Call Highlights
Key Points
- Interested in Knight-Swift Transportation Holdings Inc.? Here are five stocks we like better.
- Knight-Swift said the truckload market tightened sharply in Q2 2026, with spot rates
Crown Castle Q2 Earnings Call Highlights
Key Points
- Interested in Crown Castle Inc.? Here are five stocks we like better.
- Crown Castle reported solid Q2 2026 results and raised full-year guidance, lifting both site rental revenue and
Belite Bio Conference Highlights Tinlarebant Data and New Hope for Retinal Diseases
Key Points
- Interested in Belite Bio, Inc. Sponsored ADR? Here are five stocks we like better.
- Belite Bio highlighted positive tinlarebant data from its DRAGON trial in Stargardt disease
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
Key Points
- Interested in Repligen Corporation? Here are five stocks we like better.
- Repligen is acquiring BioLife Solutions in a deal valued at about $1.5 billion, paying $31 per share in a
AT&T Q2 Earnings Call Highlights
Key Points
- Interested in AT&T Inc.? Here are five stocks we like better.
- AT&T delivered stronger Q2 results, with service revenue up 2.7%, adjusted EBITDA up 5.2%, and adjusted EPS rising to
Dr. Reddy's Laboratories Q1 Earnings Call Highlights
Key Points
- Interested in Dr. Reddy's Laboratories Ltd? Here are five stocks we like better.
- Dr. Reddy’s Q1 revenue fell 5.6% year over year to INR 8,071 crores, while EBITDA margin dropped to
Chubb Q2 Earnings Call Highlights
Key Points
- Interested in Chubb Limited? Here are five stocks we like better.
- Chubb delivered a strong Q2 with core operating earnings of $2.8 billion, or $7.26 per share, up sharply from a
Healthcare Services Group Q2 Earnings Call Highlights
Key Points
- Interested in Healthcare Services Group, Inc.? Here are five stocks we like better.
- Healthcare Services Group reported Q2 2026 revenue of $470.8 million and net income of $22.7
Celldex Therapeutics Scraps PN Plans After Barzolvolimab Phase 2 Miss
Celldex Therapeutics (NASDAQ:CLDX) said a Phase 2 trial of barzolvolimab in prurigo nodularis did not meet its primary or secondary endpoints, prompting the company to discontinue development of
AMD Aktie: Alles auf eine Karte?
Advanced Micro Devices steuert auf einen der wichtigsten Termine des Börsenjahres zu. Am 22.…
Der Beitrag AMD Aktie: Alles auf eine Karte? erschien zuerst auf kapitalmarktexperten.de.
Quelle kapital